The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
5 Biggest Blockchain ETFs in 2025
next post
Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

McEwen to Acquire Canadian Gold in All-share Deal

October 17, 2025

Los Andes Copper at 121 Mining Investment London

May 9, 2025

High Resolution Ground Magnetics Commences at 100% –...

March 4, 2025

Forte Minerals to Present at the Swiss Mining...

March 15, 2025

SAGA Metals Confirms a 3 km Continuous Magnetic...

August 6, 2025

Questcorp and Riverside Update Substantial Drilling Progress at...

October 16, 2025

Top 11 Countries by Rare Earth Metal Production

February 27, 2025

White Gold Corp. Discovers 1 km Long Gold-In-Soil...

February 23, 2024

R3D Secures Additional Funding

March 16, 2024

Altech Batteries LtdCERENERGY Accredited Highest Possible Green Rating

January 24, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,579)
    • Investing (4,768)
    • Politics (6,256)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved